{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:44:36Z","timestamp":1786985076590,"version":"build-2736575974"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["16H01779"],"award-info":[{"award-number":["16H01779"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17K2003807"],"award-info":[{"award-number":["17K2003807"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17K08425"],"award-info":[{"award-number":["17K08425"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.bcp.2018.06.027","type":"journal-article","created":{"date-parts":[[2018,6,23]],"date-time":"2018-06-23T19:51:16Z","timestamp":1529783476000},"page":"172-181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Molecular and functional characterization of UDP-glucuronosyltransferase 1A in cynomolgus macaques"],"prefix":"10.1016","volume":"155","author":[{"given":"Yasuhiro","family":"Uno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rika","family":"Takahira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norie","family":"Murayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Ikenaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayumi","family":"Ishizuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Ikushiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2018.06.027_b0005","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1146\/annurev.pharmtox.40.1.581","article-title":"Human UDP-glucuronosyltransferases: metabolism, expression, and disease","volume":"40","author":"Tukey","year":"2000","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.bcp.2018.06.027_b0010","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0009-2797(00)00198-8","article-title":"Roles of glucuronidation and UDP-glucuronosyltransferases in xenobiotic bioactivation reactions","volume":"129","author":"Ritter","year":"2000","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bcp.2018.06.027_b0015","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/01.fpc.0000173483.13689.56","article-title":"Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily","volume":"15","author":"Mackenzie","year":"2005","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.bcp.2018.06.027_b0020","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3109\/03602530903210682","article-title":"UGT genomic diversity: beyond gene duplication","volume":"42","author":"Guillemette","year":"2010","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.bcp.2018.06.027_b0025","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3109\/03602532.2010.549492","article-title":"Macaque cytochromes P450: nomenclature, transcript, gene, genomic structure, and function","volume":"43","author":"Uno","year":"2011","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.bcp.2018.06.027_b0030","doi-asserted-by":"crossref","first-page":"142","DOI":"10.2174\/138920010791110854","article-title":"Macaque CYP2C76 encodes cytochrome P450 enzyme not orthologous to any human isozymes","volume":"11","author":"Uno","year":"2010","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.bcp.2018.06.027_b0035","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1124\/mol.106.022673","article-title":"CYP2C76, a novel cytochrome P450 in cynomolgus monkey, is a major CYP2C in liver, metabolizing tolbutamide and testosterone","volume":"70","author":"Uno","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2018.06.027_b0040","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1080\/00498250600968275","article-title":"CYP2C76-mediated species difference in drug metabolism: a comparison of pitavastatin metabolism between monkeys and humans","volume":"37","author":"Uno","year":"2007","journal-title":"Xenobiotica"},{"key":"10.1016\/j.bcp.2018.06.027_b0045","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1124\/dmd.114.061275","article-title":"Evaluation of 89 compounds for identification of substrates for cynomolgus monkey CYP2C76, a new bupropion\/nifedipine oxidase","volume":"43","author":"Hosaka","year":"2015","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2018.06.027_b0050","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1742-7843.2011.00740.x","article-title":"Metabolism of P450 probe substrates by cynomolgus monkey CYP2C76","volume":"109","author":"Uno","year":"2011","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.bcp.2018.06.027_b0055","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.bcp.2010.11.003","article-title":"CYP1D1, pseudogenized in human, is expressed and encodes a functional drug-metabolizing enzyme in cynomolgus monkey","volume":"81","author":"Uno","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2018.06.027_b0060","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1124\/dmd.110.036574","article-title":"CYP2G2, pseudogenized in human, is expressed in nasal mucosa of cynomolgus monkey and encodes a functional drug-metabolizing enzyme","volume":"39","author":"Uno","year":"2011","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2018.06.027_b0065","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.lfs.2010.07.001","article-title":"Functional characterization of human and cynomolgus monkey UDP-glucuronosyltransferase 1A1 enzymes","volume":"87","author":"Hanioka","year":"2010","journal-title":"Life Sci."},{"key":"10.1016\/j.bcp.2018.06.027_b0070","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0960-0760(01)00062-0","article-title":"Isolation and characterization of the monkey UDP-glucuronosyltransferase cDNA clone monUGT1A01 active on bilirubin and estrogens","volume":"77","author":"Vall\u00e9e","year":"2001","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bcp.2018.06.027_b0075","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.cbi.2006.09.006","article-title":"Functional characterization of human and cynomolgus monkey UDP-glucuronosyltransferase 1A6 enzymes","volume":"164","author":"Hanioka","year":"2006","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bcp.2018.06.027_b0080","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1210\/endo.140.7.6853","article-title":"The monkey and human uridine diphosphate-glucuronosyltransferase UGT1A9, expressed in steroid target tissues, are estrogen-conjugating enzymes","volume":"140","author":"Albert","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.bcp.2018.06.027_b0085","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s13318-014-0177-x","article-title":"Functional characterization of cynomolgus monkey UDP-glucuronosyltransferase 1A9","volume":"39","author":"Yamamoto","year":"2014","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.bcp.2018.06.027_b0090","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1471-2148-7-69","article-title":"Adaptive evolution of multiple-variable exons and structural diversity of drug-metabolizing enzymes","volume":"7","author":"Li","year":"2007","journal-title":"BMC Evol. Biol."},{"key":"10.1016\/j.bcp.2018.06.027_b0095","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1124\/jpet.111.185009","article-title":"Immunochemical detection of cytochrome P450 enzymes in liver microsomes of 27 cynomolgus monkeys","volume":"339","author":"Uehara","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2018.06.027_b0100","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.bbagen.2004.02.012","article-title":"Functional co-expression of xenobiotic metabolizing enzymes, rat cytochrome P450 1A1 and UDP-glucuronosyltransferase 1A6, in yeast microsomes","volume":"1672","author":"Ikushiro","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bcp.2018.06.027_b0105","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1089\/dna.1985.4.203","article-title":"Expression of rat liver cytochrome P-450MC cDNA in Saccharomyces cerevisiae","volume":"4","author":"Oeda","year":"1985","journal-title":"DNA (Mary Ann Liebert, Inc)"},{"key":"10.1016\/j.bcp.2018.06.027_b0110","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2133\/dmpk.21.70","article-title":"Monospecific antipeptide antibodies against human hepatic UDP-glucuronosyltransferase 1A subfamily (UGT1A) isoforms","volume":"21","author":"Ikushiro","year":"2006","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.bcp.2018.06.027_b0115","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/0049825021000022348","article-title":"Catalytic activities of cytochrome P450 enzymes and UDP-glucuronosyltransferases involved in drug metabolism in rat everted sacs and intestinal microsomes","volume":"33","author":"Takemoto","year":"2003","journal-title":"Xenobiotica"},{"key":"10.1016\/j.bcp.2018.06.027_b0120","doi-asserted-by":"crossref","first-page":"e16923","DOI":"10.1371\/journal.pone.0016923","article-title":"Newly identified CYP2C93 is a functional enzyme in rhesus monkey, but not in cynomolgus monkey","volume":"6","author":"Uno","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2018.06.027_b0125","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3109\/00498254.2011.618954","article-title":"Quantitative distribution of mRNAs encoding the 19 human UDP-glucuronosyltransferase enzymes in 26 adult and 3 fetal tissues","volume":"42","author":"Court","year":"2012","journal-title":"Xenobiotica"},{"key":"10.1016\/j.bcp.2018.06.027_b0130","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1124\/dmd.108.023598","article-title":"Determination of mRNA expression of human UDP-glucuronosyltransferases and application for localization in various human tissues by real-time reverse transcriptase-polymerase chain reaction","volume":"37","author":"Ohno","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2018.06.027_b0135","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1124\/dmd.108.021428","article-title":"Expression of UGT1A and UGT2B mRNA in human normal tissues and various cell lines","volume":"36","author":"Nakamura","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2018.06.027_b0140","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3109\/03602532.2014.973037","article-title":"Transcriptional regulation of human UDP-glucuronosyltransferase genes","volume":"46","author":"Hu","year":"2014","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.bcp.2018.06.027_b0145","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3109\/03602530903209544","article-title":"The regulation of UDP-glucuronosyltransferase genes by tissue-specific and ligand-activated transcription factors","volume":"42","author":"Mackenzie","year":"2010","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.bcp.2018.06.027_b0150","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1124\/dmd.109.027227","article-title":"Quantitative analysis of UDP-glucuronosyltransferase (UGT) 1A and UGT2B expression levels in human livers","volume":"37","author":"Izukawa","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2018.06.027_b0155","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1124\/dmd.108.022731","article-title":"The configuration of the 17-hydroxy group variably influences the glucuronidation of \u03b2-estradiol and epiestradiol by human UDP-glucuronosyltransferases","volume":"36","author":"It\u00e4aho","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2018.06.027_b0160","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/0049825021000048809","article-title":"Serotonin (5-hydroxytryptamine) glucuronidation in vitro: assay development, human liver microsome activities and species differences","volume":"33","author":"Krishnaswamy","year":"2003","journal-title":"Xenobiotica"},{"key":"10.1016\/j.bcp.2018.06.027_b0165","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0076-6879(05)00007-8","article-title":"Isoform-selective probe substrates for in vitro studies of human UDP-glucuronosyltransferases","volume":"400","author":"Court","year":"2005","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.bcp.2018.06.027_b0170","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.bcp.2012.08.026","article-title":"Effects of amino acid substitutions at positions 33 and 37 on UDP-glucuronosyltransferase 1A9 (UGT1A9) activity and substrate selectivity","volume":"84","author":"Korprasertthaworn","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2018.06.027_b0175","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1124\/jpet.103.054072","article-title":"Novel functional polymorphisms in the UGT1A7 and UGT1A9 glucuronidating enzymes in Caucasian and African-American subjects and their impact on the metabolism of 7-ethyl-10-hydroxycamptothecin and flavopiridol anticancer drugs","volume":"307","author":"Villeneuve","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2018.06.027_b0180","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1124\/dmd.108.022913","article-title":"Key amino acid residues responsible for the differences in substrate specificity of human UDP-glucuronosyltransferase (UGT)1A9 and UGT1A8","volume":"37","author":"Fujiwara","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2018.06.027_b0185","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3109\/00498254.2013.828362","article-title":"Species differences in intestinal glucuronidation activities between humans, rats, dogs and monkeys","volume":"44","author":"Furukawa","year":"2014","journal-title":"Xenobiotica"},{"key":"10.1016\/j.bcp.2018.06.027_b0190","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3109\/00498254.2015.1074301","article-title":"Raloxifene glucuronidation in liver and intestinal microsomes of humans and monkeys: contribution of UGT1A1, UGT1A8 and UGT1A9","volume":"46","author":"Kishi","year":"2016","journal-title":"Xenobiotica"},{"key":"10.1016\/j.bcp.2018.06.027_b0195","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1159\/000165100","article-title":"Stereoselective glucuronidation of propranolol in human and cynomolgus monkey liver microsomes: role of human hepatic UDP-glucuronosyltransferase isoforms, UGT1A9, UGT2B4 and UGT2B7","volume":"82","author":"Hanioka","year":"2008","journal-title":"Pharmacology"},{"key":"10.1016\/j.bcp.2018.06.027_b0200","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1124\/dmd.106.009274","article-title":"N-glucuronidation of the platelet-derived growth factor receptor tyrosine kinase inhibitor 6,7-(dimethoxy-2,4-dihydroindeno[1,2-C]pyrazol-3-yl)-(3-fluoro-phenyl)-amine by human UDP-glucuronosyltransferases","volume":"34","author":"Yan","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2018.06.027_b0205","doi-asserted-by":"crossref","first-page":"652","DOI":"10.3109\/00498254.2011.563327","article-title":"N-glucuronidation of drugs and other xenobiotics by human and animal UDP-glucuronosyltransferases","volume":"41","author":"Kaivosaari","year":"2011","journal-title":"Xenobiotica"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295218302429?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295218302429?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T04:17:02Z","timestamp":1576815422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295218302429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":41,"alternative-id":["S0006295218302429"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2018.06.027","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular and functional characterization of UDP-glucuronosyltransferase 1A in cynomolgus macaques","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2018.06.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}